About VAXX

VAXX, Inc. is an Arizona-based product-focused biotechnology company with the mission of developing new plant-produced biopharmaceuticals.

VAXX's business model is to develop products to the clinical proof-of-principle stage, then complete development, obtain licensure, and market its products through commercial partnerships. The company's asset base consists of technology licenses that provide it with freedom to operate. VAXX does not intend to build infrastructure. Rather, the company will use R&D proceeds derived from investors and partners to efficiently and cost-effectively manage product development programs, while retaining rights to commercialize its products through business alliances.